new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Nerviano Medical Sciences S r l
Nerviano Medical Sciences S r l A Corporation
  

Nerviano Medical Sciences S r l patents

Recent patent applications related to Nerviano Medical Sciences S r l. Nerviano Medical Sciences S r l is listed as an Agent/Assignee. Note: Nerviano Medical Sciences S r l may have other listings under different names/spellings. We're not affiliated with Nerviano Medical Sciences S r l, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "N" | Nerviano Medical Sciences S r l-related inventors




Date Nerviano Medical Sciences S r l patents (updated weekly) - BOOKMARK this page
03/16/17Thieno-indole moieties and methods of treating using the same
02/23/17Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
01/12/17Methods for treating neuroblastoma
10/27/16Substituted indazole derivatives active as kinase inhibitiors
10/27/16Substituted indazole derivatives active as kinase inhibitiors
09/29/16Process for the preparation of n-[5-(3,5-difluoro-benzyl)-1h-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide
08/11/16Thieno[2,3-e]indole derivatives as new antitumor agents
06/16/16Pyrrolo[2,3-d]pyrimidine derivatives, process for their preparation and their use as kinase inhibitors
04/07/16Substituted indazole derivatives active as kinase inhibitors
03/17/16New morpholinyl anthracycline derivatives
11/19/15Tricyclopyrazole derivatives
10/22/15Substituted pyrimidinyl and pyridinyl-pyrrolopyridinones, process for their preparation and their use as kinase inhibitors
10/15/15Functionalized 9-bromo-camptothecin derivatives
10/01/154-carboxamido-isoindolinone derivatives as selective parp-1 inhibitors
10/01/15Process for the preparation of n-[5-(3,5-difluoro-benzyl)-1h-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide
08/06/15Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
06/18/15Substituted pyrroles active as kinases inhibitors
06/11/15Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
05/21/15Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
03/19/15Functionalized thieno-indole derivatives for the treatment of cancer
03/19/15Functionalized thieno-indole derivatives for the treatment of cancer
03/05/15Substituted indazole derivatives active as kinase inhibitors
02/26/15Substituted indazole derivatives active as kinase inhibitors
02/26/15Substituted indazole derivatives active as kinase inhibitors
02/19/15Alkylating agents
02/19/15Process for the preparation of n-[5-(3,5-difluoro-benzyl)-1h-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide
02/19/15Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
09/04/144-alkyl substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2h)-one derivatives as kinases inhibitors
08/28/14Substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2h)-one derivatives as kinases inhibitors
08/21/143-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors
08/14/14Substituted indazole derivatives active as kinase inhibitors
07/10/14Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors
06/05/14Substituted pyrimidinyl-pyrroles active as kinase inhibitors
03/20/14Substituted indazole derivatives active as kinase inhibitors
02/20/14Pyrazolyl-pyrimidine derivatives as kinase inhibitors
02/13/14[1,2,4]triazolo[1,5-c]pyrimidine derivatives as hsp90 modulators
02/13/14Isoquinolin-1(2h)-one derivatives as parp-1 inhibitors
01/02/143,4-diarylpyrazoles as protein kinase inhibitors
12/26/13Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
12/26/13Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors
12/19/13Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
12/05/13Thiazolylphenyl-benzenesulfonamido derivatives as kinase inhibitors
11/14/13Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
11/07/13Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
08/08/13Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs
06/06/13Isoxazolo-quinazolines as modulators of protein kinase activity
05/30/133,4-dihydro-2h-pyrrolo[1,2-a]pyrazin-1-one derivatives for the modulation of the activity of protein kinases
05/23/13Therapeutic combination comprising a parp-1 inhibitor and an anti-neoplastic agent
01/31/136,7-dihydroimidazo[1,5-a]pyrazin-8(5h)-one derivatives as protein kinase modulators
01/17/13Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
01/17/13Substituted indazole derivatives active as kinase inhibitors
01/10/13Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
11/22/12Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furane-derivatives as kinase inhibitors
11/01/12Therapeutic combination comprising a cdc7 inhibitor and an anti-neoplastic agent
11/01/12Tricyclopyrazole derivatives
11/01/12Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
09/27/123-oxo-2,3-dihydro-1h-isoindole-4-carboxamides as parp inhibitors
09/27/123-0x0-2,3-dihydro-1h-isoindole-4-carboxamides with selective parp-1 inhibition
09/27/12Crystalline cdc7 inhibitor salts
09/13/123,4-dihydro-2h-pyrazino[1,2-a]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
08/30/12Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1h-pyrrole-3-carboxamides
07/19/12[1,2,4]triazolo [1,5-c]pyrimidine derivatives as hsp90 modulators
07/12/12Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors
06/28/121h-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
06/21/12Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors
Patent Packs
06/21/12Plk inhibitor salts
05/17/12Pharmaceutical composition of an anthracycline
05/17/12Substituted pyrrolo-pyrimidine derivatives, process for their preparation and their use as kinase inhibitors
05/10/12Therapeutic combination comprising a plk1 inhibitor and an antineoplastic agent
03/29/12Use of kinase inhibitor for the treatment of thymoma
03/15/12N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors
02/23/12Resorcinol derivatives as hsp90 inhibitors
02/16/12Cdk inhibitor salts
12/22/11Therapeutic combination comprising a cdks inhibitor and an antineoplastic agent
12/01/11Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
11/17/11Substituted indazole derivatives active as kinase inhibitors
10/20/11Bicyclic pyrazoles as protein kinase inhibitors
10/13/113,4-dihydro-2h-pyrrolo[1,2-a]pyrazin-1-one derivatives
09/22/11Substituted pyrazolo[4,3-c]pyridine derivatives active as kinase inhibitors
09/15/11Cdk inhibitor for the treatment of mesothelioma
Patent Packs
08/04/11Use of cdk inhibitor for the treatment of glioma
07/28/113,4-dihydro-2h-pyrazino[1,2-a]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/16/113,4-diarylpyrazoles as protein kinase inhibitors
06/02/11Therapeutic combination comprising an aurora kinase inhibitor and antiproliferative agents
05/19/11Therapeutic combination comprising an aurora kinase inhibitor and an antineoplastic agent
05/19/11Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs
05/05/11Pyrazolo--quinazolines
03/03/11Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors
02/17/11Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1h-pyrrole-3-carboxamides
01/27/11Antitumor combination comprising a morpholinyl anthracycline derivative and demethylating agents
11/18/10Substituted indazole derivatives active as kinase inhibitors
10/07/10Method of administering an antitumor compound
08/26/10Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
08/05/10Indazole derivatives as kinase inhibitors for the treatment of cancer
07/29/10Morpholinyl anthracycline derivative combined with protein kinase inhibitors
04/29/10Antitumor combination comprising a morpholinyl anthracycline and an antibody
03/25/10Tricyclic indoles and (4,5-dihydro) indoles
03/18/10Crystalline nemorubicin hydrochloride
03/04/10Isoquinolinopyrrolopyridinones active as kinase inhibitors
02/11/10Use of a kinase inhibitor for the treatment of particular resistant tumors
01/28/10Use of a kinase inhibitor for the treatment of particular resistant tumors
01/28/10Therapeutic combination comprising an aurora kinase inhibitor and imatinib
01/14/10Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
09/24/091h-furo[3,2-c]pyrazole compounds useful as kinase inhibitors
06/25/09Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors
06/11/091h-thieno[2,3-c]pyrazole compounds useful as kinase inhibitors
05/28/09Bicyclo-pyrazoles active as kinase inhibitors
05/14/09Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
04/16/09Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furane-derivatives as kinase inhibitors
11/13/143-phenyl-isoquinolin-1(2h)-one derivatives as parp-1 inhibitors
Social Network Patent Pack







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Nerviano Medical Sciences S r l in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Nerviano Medical Sciences S r l with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';